Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

by

CTech 24/7

More stories in CTech

Pontifax

7 stories about Pontifax

Which Israeli company struck a $90 million deal thanks to the demand for salmon and who crossed $1.3 billion funding threshold?
12.10.20|CTechCTech Daily Roundup: U.S. presidential elections no more than background noise for volatile markets
Due to high demand for biotech, Pontifax crosses $1.3 billion funding threshold
12.10.20|Tzally GreenbergA series of successful exits and investments see the Israeli fund balloon by 22% to hit $404 million since the start of the Covid-19 crisis
Biological cancer treatment company Novellus raises $57 million
22.09.20|Tzally GreenbergNovellus develops a drug that delays the development of a BRAF gene mutation created in cases of thyroid cancer and glioma cancer
Life Science Investment Firm Pontifax Raises $170 Million Fund
22.11.18|Meir OrbachThe firm’s new fund, its sixth, will focus on credit loans to pharmaceutical companies planning to go public
Merck and WuXi AppTec Announce Launch of Biotech Incubator in Israel
20.02.18|Meir OrbachThe incubator program has a five year budget of 20 million euros
CTech’s Daily Israeli Tech News Roundup
01.01.18|CTechWith a steady hand, Check Point CEO leads company to new post dot-com heights. Israeli shelf company sued for misleading investors with crypto-filing. New coworking space opens on the highest floors of Israel's highest building
Pontifax Raises a $240 Million Fifth Fund
01.01.18|Meir OrbachLife sciences-focused venture capital firm Pontifax is expected to invest most of the new fund in the pharmaceutical industry

About CTech Terms of Use Privacy Policy

Back to Top